No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr2:113868600-113875400 |
Enhancers |
Primary monocytes fromperipheralblood |
blood
|
2 |
chr2:113871400-113875000 |
Bivalent Enhancer |
HepG2 |
liver
|
3 |
chr2:113871400-113875400 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
4 |
chr2:113871600-113875400 |
Enhancers |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
5 |
chr2:113871800-113875400 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
6 |
chr2:113872600-113875600 |
Enhancers |
Primary B cells from peripheral blood |
blood
|
7 |
chr2:113872800-113875000 |
Enhancers |
Primary T cells from cord blood |
blood
|
8 |
chr2:113872800-113875000 |
Enhancers |
Primary Natural Killer cells fromperipheralblood |
blood
|
9 |
chr2:113873000-113875200 |
Enhancers |
Primary T helper cells PMA-I stimulated |
--
|
10 |
chr2:113873000-113875200 |
Weak transcription |
Fetal Adrenal Gland |
Adrenal Gland
|
11 |
chr2:113873000-113875400 |
Enhancers |
Stomach Mucosa |
stomach
|
12 |
chr2:113873000-113875600 |
Enhancers |
Primary hematopoietic stem cells |
blood
|
13 |
chr2:113873000-113875600 |
Enhancers |
Primary T helper 17 cells PMA-I stimulated |
--
|
14 |
chr2:113873200-113875400 |
Enhancers |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
15 |
chr2:113873200-113875400 |
Enhancers |
Spleen |
Spleen
|
16 |
chr2:113873200-113876000 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
17 |
chr2:113873400-113875000 |
Weak transcription |
Lung |
lung
|
18 |
chr2:113873400-113875600 |
Enhancers |
Duodenum Mucosa |
Duodenum
|
19 |
chr2:113873600-113875400 |
Weak transcription |
Placenta |
Placenta
|
20 |
chr2:113873600-113876000 |
Enhancers |
Placenta Amnion |
Placenta Amnion
|
21 |
chr2:113873600-113876000 |
Enhancers |
Rectal Mucosa Donor 31 |
rectum
|
22 |
chr2:113874000-113875600 |
Enhancers |
HMEC |
breast
|
23 |
chr2:113874200-113876000 |
Enhancers |
NHDF-Ad |
bronchial
|
24 |
chr2:113874200-113877200 |
Enhancers |
Primary hematopoietic stem cells short term culture |
blood
|
25 |
chr2:113874400-113875000 |
Bivalent Enhancer |
Primary T cells fromperipheralblood |
blood
|
26 |
chr2:113874400-113875000 |
Enhancers |
Colonic Mucosa |
Colon
|
27 |
chr2:113874400-113875000 |
Flanking Active TSS |
Esophagus |
oesophagus
|
28 |
chr2:113874400-113875600 |
Enhancers |
Monocytes-CD14+_RO01746 |
blood
|
29 |
chr2:113874400-113875800 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
30 |
chr2:113874400-113875800 |
Enhancers |
Fetal Muscle Leg |
muscle
|
31 |
chr2:113874400-113877000 |
Weak transcription |
Sigmoid Colon |
Sigmoid Colon
|
32 |
chr2:113874600-113875000 |
Enhancers |
Small Intestine |
intestine
|
33 |
chr2:113874600-113875800 |
Enhancers |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|
34 |
chr2:113874600-113876000 |
Enhancers |
K562 |
blood
|
35 |
chr2:113874600-113877600 |
Enhancers |
Primary neutrophils fromperipheralblood |
blood
|
36 |
chr2:113874600-113878400 |
Weak transcription |
GM12878-XiMat |
blood
|
37 |
chr2:113874800-113875000 |
Bivalent Enhancer |
Primary B cells from cord blood |
blood
|
38 |
chr2:113874800-113875200 |
Flanking Active TSS |
NHEK |
skin
|
39 |
chr2:113874800-113875400 |
Enhancers |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
40 |
chr2:113874800-113875400 |
Weak transcription |
Gastric |
stomach
|
41 |
chr2:113874800-113875600 |
Bivalent Enhancer |
Foreskin Fibroblast Primary Cells skin02 |
Skin
|
42 |
chr2:113874800-113875600 |
Enhancers |
Osteobl |
bone
|
43 |
chr2:113874800-113875800 |
Enhancers |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
44 |
chr2:113874800-113875800 |
Enhancers |
NH-A |
brain
|
45 |
chr2:113874800-113878800 |
Weak transcription |
Primary T helper cells fromperipheralblood |
blood
|